Inogen, Inc.
INGNNASDAQHealthcare● Active
$6.06
$-0.35(-5.46%)
Market Cap$164071567
P/E Ratio—
52W High$9.13
52W Low$5.34
Inogen, Inc. (INGN) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · INGN · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.35B | $0.34B | $0.32B | $0.38B | $0.36B |
| Cost of Revenue | $0.18B | $0.18B | $0.19B | $0.22B | $0.18B |
| Gross Profit | $0.17B | $0.15B | $0.13B | $0.15B | $0.18B |
| Gross Margin %(computed) | 47.58% | 46.09% | 40.14% | 40.70% | 49.30% |
| Operating Expenses | |||||
| R&D Expenses | $0.02B | $0.02B | $0.02B | $0.02B | $0.02B |
| G&A Expenses | $0.07B | $0.07B | $0.08B | $0.04B | $0.04B |
| Total Operating Expenses | $0.20B | $0.20B | $0.24B | $0.24B | $0.17B |
| Operating Income | ($0.03B) | ($0.04B) | ($0.11B) | ($0.09B) | $0.01B |
| Operating Margin %(computed) | -8.66% | -12.66% | -34.65% | -22.60% | 2.58% |
| Interest Income | $0.00B | $0.01B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.02B) | ($0.04B) | ($0.10B) | ($0.08B) | $0.01B |
| Income Tax Expense | ($0.00B) | ($0.00B) | $0.00B | $0.00B | $0.01B |
| Net Income | ($0.02B) | ($0.04B) | ($0.10B) | ($0.08B) | ($0.01B) |
| Net Margin %(computed) | -6.52% | -10.69% | -32.46% | -22.21% | -1.77% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.85 | $-1.52 | $-4.42 | $-3.67 | $-0.28 |
| Wtd Avg Shares | 0.03B | 0.02B | 0.02B | 0.02B | 0.02B |
| EBITDA | ($0.00B) | ($0.02B) | ($0.06B) | ($0.01B) | $0.03B |
| EBITDA Margin %(computed) | -0.78% | -6.41% | -18.48% | -2.54% | 8.62% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Inogen, Inc. data
About Inogen, Inc. (INGN) Income Statement
Inogen, Inc. (INGN) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, INGN reported revenue of $0.35B, gross profit of $0.17B (gross margin 47.58%), and net income of ($0.02B) — a net profit margin of -6.52%.
Frequently asked questions
INGN · 4 questionsInogen, Inc. (INGN) reported revenue of $0.35B for 2025, up 3.9% year-over-year.
INGN revenueINGN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08